المؤلفون: Deedwania PC; UCSF School of Medicine, Fresno, CA, USA., Shepherd J; University of Glasgow, Glasgow, UK., Breazna A; Pfizer Inc, New York, NY, USA., DeMicco DA; Pfizer Inc, New York, NY, USA.

مؤلفون مشاركون: Treating to New Targets (TNT) Steering Committee Investigators

المصدر: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2016 Jan; Vol. 18 (1), pp. 56-63.

نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE

مواضيع طبية MeSH: Anticholesteremic Agents/*pharmacology , Atorvastatin/*pharmacology , Cardiovascular Diseases/*prevention & control , Cholesterol, LDL/*drug effects , Metabolic Syndrome/*drug therapy, Adult ; Aged ; Anticholesteremic Agents/administration & dosage ; Atorvastatin/administration & dosage ; Blood Glucose/analysis ; Body Mass Index ; Cardiovascular Diseases/etiology ; Cholesterol, HDL/blood ; Cholesterol, LDL/blood ; Dose-Response Relationship, Drug ; Double-Blind Method ; Fasting/blood ; Female ; Humans ; Hypertension/complications ; Male ; Metabolic Syndrome/blood ; Metabolic Syndrome/complications ; Middle Aged ; Predictive Value of Tests ; Risk Factors ; Triglycerides/blood

المؤلفون: Sattar N; British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK. nsattar@clinmed.gla.ac.uk, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, Seshasai SR, McMurray JJ, Freeman DJ, Jukema JW, Macfarlane PW, Packard CJ, Stott DJ, Westendorp RG, Shepherd J, Davis BR, Pressel SL, Marchioli R, Marfisi RM, Maggioni AP, Tavazzi L, Tognoni G, Kjekshus J, Pedersen TR, Cook TJ, Gotto AM, Clearfield MB, Downs JR, Nakamura H, Ohashi Y, Mizuno K, Ray KK, Ford I

المصدر: Lancet (London, England) [Lancet] 2010 Feb 27; Vol. 375 (9716), pp. 735-42. Date of Electronic Publication: 2010 Feb 16.

نوع المنشور: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

مواضيع طبية MeSH: Anticholesteremic Agents/*adverse effects , Cardiovascular Diseases/*drug therapy , Diabetes Mellitus, Type 2/*chemically induced , Hydroxymethylglutaryl-CoA Reductase Inhibitors/*adverse effects, Age Distribution ; Age Factors ; Aged ; Diabetes Mellitus, Type 2/epidemiology ; Female ; Humans ; Male ; Middle Aged ; Randomized Controlled Trials as Topic ; Risk Factors ; Treatment Outcome

المؤلفون: LaRosa JC; State University of New York, Health Science Center, Brooklyn, New York, USA. jclarosa@downstate.edu, Deedwania PC, Shepherd J, Wenger NK, Greten H, DeMicco DA, Breazna A

مؤلفون مشاركون: TNT Investigators

المصدر: The American journal of cardiology [Am J Cardiol] 2010 Feb 01; Vol. 105 (3), pp. 283-7. Date of Electronic Publication: 2009 Dec 22.

نوع المنشور: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Excerpta Medica Country of Publication: United States NLM ID: 0207277 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1913 (Electronic) Linking ISSN: 00029149 NLM ISO Abbreviation: Am J Cardiol Subsets: MEDLINE

مواضيع طبية MeSH: Anticholesteremic Agents/*administration & dosage , Coronary Disease/*drug therapy , Coronary Restenosis/*prevention & control , Heart Failure/*prevention & control , Heptanoic Acids/*administration & dosage , Metabolic Syndrome/*drug therapy , Pyrroles/*administration & dosage, Aged ; Atorvastatin ; Coronary Disease/complications ; Diabetes Complications/drug therapy ; Double-Blind Method ; Drug Administration Schedule ; Heart Diseases/prevention & control ; Humans ; Metabolic Syndrome/complications ; Risk Factors ; Treatment Outcome

المؤلفون: Taylor DC; i3 Innovus, 10 Cabot Road, Suite 304, Medford, MA 02155, USA. douglas.taylor@i3innovus.com, Pandya A, Thompson D, Chu P, Graff J, Shepherd J, Wenger N, Greten H, Carmena R, Drummond M, Weinstein MC

المصدر: The European journal of health economics : HEPAC : health economics in prevention and care [Eur J Health Econ] 2009 Jul; Vol. 10 (3), pp. 255-65. Date of Electronic Publication: 2008 Sep 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 101134867 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1618-7598 (Print) Linking ISSN: 16187598 NLM ISO Abbreviation: Eur J Health Econ Subsets: MEDLINE

مواضيع طبية MeSH: Anticholesteremic Agents/*economics , Anticholesteremic Agents/*therapeutic use , Cardiovascular Diseases/*drug therapy , Cardiovascular Diseases/*prevention & control , Heptanoic Acids/*economics , Heptanoic Acids/*therapeutic use , Pyrroles/*economics , Pyrroles/*therapeutic use, Anticholesteremic Agents/administration & dosage ; Atorvastatin ; Cost-Benefit Analysis ; Dose-Response Relationship, Drug ; Europe ; Heptanoic Acids/administration & dosage ; Humans ; Markov Chains ; Pyrroles/administration & dosage ; Quality-Adjusted Life Years

المؤلفون: Shepherd J; University of Glasgow, United Kingdom. jshepherd@gri-biochem.org.uk, Kastelein JP, Bittner VA, Carmena R, Deedwania PC, Breazna A, Dobson S, Wilson DJ, Zuckerman AL, Wenger NK

مؤلفون مشاركون: Treating to New Targets Steering Committee and Investigators

المصدر: Mayo Clinic proceedings [Mayo Clin Proc] 2008 Aug; Vol. 83 (8), pp. 870-9.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: [Oxford, England] Country of Publication: England NLM ID: 0405543 Publication Model: Print Cited Medium: Internet ISSN: 1942-5546 (Electronic) Linking ISSN: 00256196 NLM ISO Abbreviation: Mayo Clin Proc Subsets: MEDLINE

مواضيع طبية MeSH: Anticholesteremic Agents/*administration & dosage , Cardiovascular Diseases/*prevention & control , Coronary Disease/*complications , Diabetes Mellitus, Type 2/*complications , Heptanoic Acids/*administration & dosage , Kidney Failure, Chronic/*complications , Lipids/*blood , Pyrroles/*administration & dosage, Adult ; Aged ; Analysis of Variance ; Atorvastatin ; Cardiovascular Diseases/epidemiology ; Coronary Disease/prevention & control ; Double-Blind Method ; Female ; Follow-Up Studies ; Glomerular Filtration Rate ; Humans ; Male ; Middle Aged ; Proportional Hazards Models ; Risk ; Treatment Outcome ; United States/epidemiology

المؤلفون: Shah SJ; Division of Cardiology, San Francisco General Hospital, University of California, San Francisco, California 94110, USA., Waters DD, Barter P, Kastelein JJ, Shepherd J, Wenger NK, DeMicco DA, Breazna A, LaRosa JC

المصدر: Journal of the American College of Cardiology [J Am Coll Cardiol] 2008 May 20; Vol. 51 (20), pp. 1938-43.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Biomedical Country of Publication: United States NLM ID: 8301365 Publication Model: Print Cited Medium: Internet ISSN: 1558-3597 (Electronic) Linking ISSN: 07351097 NLM ISO Abbreviation: J Am Coll Cardiol Subsets: MEDLINE

مواضيع طبية MeSH: Anticholesteremic Agents/*administration & dosage , Coronary Artery Disease/*surgery , Coronary Restenosis/*prevention & control , Graft Occlusion, Vascular/*prevention & control , Heptanoic Acids/*administration & dosage , Pyrroles/*administration & dosage, Adult ; Aged ; Atorvastatin ; Cholesterol, LDL/blood ; Coronary Artery Bypass ; Female ; Humans ; Male ; Middle Aged ; Treatment Outcome ; Triglycerides/blood

المؤلفون: Shepherd J; University of Glasgow, Glasgow, United Kingdom. jshepherd@gri-biochem.org.uk, Kastelein JJ, Bittner V, Deedwania P, Breazna A, Dobson S, Wilson DJ, Zuckerman A, Wenger NK

مؤلفون مشاركون: TNT (Treating to New Targets) Investigators

المصدر: Journal of the American College of Cardiology [J Am Coll Cardiol] 2008 Apr 15; Vol. 51 (15), pp. 1448-54.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier Biomedical Country of Publication: United States NLM ID: 8301365 Publication Model: Print Cited Medium: Internet ISSN: 1558-3597 (Electronic) Linking ISSN: 07351097 NLM ISO Abbreviation: J Am Coll Cardiol Subsets: MEDLINE

مواضيع طبية MeSH: Anticholesteremic Agents/*therapeutic use , Coronary Artery Disease/*drug therapy , Heptanoic Acids/*therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use , Kidney Failure, Chronic/*complications , Lipids/*blood , Pyrroles/*therapeutic use, Adult ; Aged ; Atorvastatin ; Cholesterol, LDL/blood ; Cholesterol, LDL/drug effects ; Coronary Artery Disease/physiopathology ; Double-Blind Method ; Female ; Glomerular Filtration Rate/drug effects ; Humans ; Kidney Failure, Chronic/physiopathology ; Male ; Middle Aged ; Risk ; Triglycerides/blood

المؤلفون: Shepherd J; University Department of Pathological Biochemistry, Royal Infirmary, Glasgow, Scotland, UK. jshepherd@gri-biochem.org.uk

المصدر: The American journal of geriatric cardiology [Am J Geriatr Cardiol] 2008 Mar-Apr; Vol. 17 (2), pp. 108-13.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Le Jacq Communications Country of Publication: United States NLM ID: 9215283 Publication Model: Print Cited Medium: Print ISSN: 1076-7460 (Print) Linking ISSN: 10767460 NLM ISO Abbreviation: Am J Geriatr Cardiol Subsets: MEDLINE

مواضيع طبية MeSH: Anticholesteremic Agents/*therapeutic use , Dyslipidemias/*drug therapy , Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use, Adult ; Aged ; Aged, 80 and over ; Cholesterol, HDL/blood ; Cholesterol, LDL/blood ; Drug Interactions/physiology ; Drug Therapy, Combination ; Dyslipidemias/blood ; Humans ; Simvastatin/therapeutic use

المؤلفون: Shepherd J; Department of Vascular Biochemistry, University of Glasgow, G31 2ER, UK. jshepherd@gri-biochem.org.uk, Kastelein JJ, Bittner V, Deedwania P, Breazna A, Dobson S, Wilson DJ, Zuckerman A, Wenger NK

مؤلفون مشاركون: Treating to New Targets Investigators

المصدر: Clinical journal of the American Society of Nephrology : CJASN [Clin J Am Soc Nephrol] 2007 Nov; Vol. 2 (6), pp. 1131-9. Date of Electronic Publication: 2007 Oct 17.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 101271570 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1555-905X (Electronic) Linking ISSN: 15559041 NLM ISO Abbreviation: Clin J Am Soc Nephrol Subsets: MEDLINE

مواضيع طبية MeSH: Anticholesteremic Agents/*therapeutic use , Coronary Disease/*drug therapy , Heptanoic Acids/*therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use , Kidney/*drug effects , Pyrroles/*therapeutic use, Adult ; Aged ; Atorvastatin ; Blood Pressure/drug effects ; Cholesterol, HDL/blood ; Cholesterol, LDL/blood ; Coronary Disease/blood ; Coronary Disease/physiopathology ; Double-Blind Method ; Female ; Glomerular Filtration Rate/drug effects ; Heptanoic Acids/adverse effects ; Humans ; Kidney/physiopathology ; Kidney Diseases/prevention & control ; Male ; Middle Aged ; Pyrroles/adverse effects

المؤلفون: Ford I; Robertson Centre for Biostatistics, University of Glasgow, Glasgow, United Kingdom., Murray H, Packard CJ, Shepherd J, Macfarlane PW, Cobbe SM

مؤلفون مشاركون: West of Scotland Coronary Prevention Study Group

المصدر: The New England journal of medicine [N Engl J Med] 2007 Oct 11; Vol. 357 (15), pp. 1477-86.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

مواضيع طبية MeSH: Anticholesteremic Agents/*therapeutic use , Coronary Disease/*prevention & control , Hypercholesterolemia/*drug therapy , Pravastatin/*therapeutic use, Coronary Disease/mortality ; Follow-Up Studies ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Myocardial Infarction/epidemiology ; Myocardial Infarction/prevention & control